Literature DB >> 15226414

Activation loop phosphorylation controls protein kinase D-dependent activation of nuclear factor kappaB.

Peter Storz1, Heike Döppler, Alex Toker.   

Abstract

Activation of the inducible transcription factor nuclear factor kappaB (NF-kappaB) occurs in cells exposed to oxidative stress, and the serine/threonine kinase protein kinase D (PKD) is critical for signal relay to NF-kappaB. We have recently delineated two coordinated events that control PKD activation in response to oxidative stress: phosphorylation at Tyr463 by the tyrosine kinase Abl, and phosphorylation at the activation loop Ser738/Ser742 by the protein kinase C (PKC) isoform PKCdelta. The result is fully active PKD that controls NF-kappaB activation through the IkappaB kinase (IKK) complex. Here, we investigate the mechanism by which PKD controls IKK/NF-kappaB activation. Resveratrol, a potent antioxidant, blocks both PKD activation and NF-kappaB induction. In particular, resveratrol blocked PKD activation loop phosphorylation and activity, and this was caused by a specific inhibition of the Ser738/Ser742 kinase PKCdelta. On the other hand, resveratrol did not affect Abl kinase activity and had no effect on Tyr463 phosphorylation. Moreover, we show that the mechanism by which resveratrol inhibits NF-kappaB is by blocking the translocation of PKD to the IKK complex, specifically by inhibiting Ser738/Ser742 phosphorylation. We therefore propose that rather than acting as an antioxidant, resveratrol specifically blocks oxidative stress-dependent NF-kappaB activation by interfering with PKD phosphorylation and association with the IKK complex.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15226414     DOI: 10.1124/mol.104.000687

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  39 in total

Review 1.  Role of protein kinase D signaling in pancreatic cancer.

Authors:  Sushovan Guha; Suebpong Tanasanvimon; James Sinnett-Smith; Enrique Rozengurt
Journal:  Biochem Pharmacol       Date:  2010-07-16       Impact factor: 5.858

2.  What is Xenohormesis?

Authors:  Joseph A Baur; David A Sinclair
Journal:  Am J Pharmacol Toxicol       Date:  2008-03-31

3.  Enhancing responsiveness of human jejunal enteroids to host and microbial stimuli.

Authors:  Wenly Ruan; Melinda A Engevik; Alexandra L Chang-Graham; Heather A Danhof; Annie Goodwin; Kristen A Engevik; Zhongcheng Shi; Anne Hall; Sara C Di Rienzi; Susan Venable; Robert A Britton; Joseph Hyser; James Versalovic
Journal:  J Physiol       Date:  2020-06-13       Impact factor: 5.182

4.  Optical and SPION-enhanced MR imaging shows that trans-stilbene inhibitors of NF-κB concomitantly lower Alzheimer's disease plaque formation and microglial activation in AβPP/PS-1 transgenic mouse brain.

Authors:  Nathan O Solberg; Ryan Chamberlin; Jenette R Vigil; Lorraine M Deck; John E Heidrich; David C Brown; Christina I Brady; Thomas A Vander Jagt; Michael Garwood; Marco Bisoffi; Virginia Severns; David L Vander Jagt; Laurel O Sillerud
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 5.  The substrates and binding partners of protein kinase Cepsilon.

Authors:  Philip M Newton; Robert O Messing
Journal:  Biochem J       Date:  2010-03-29       Impact factor: 3.857

Review 6.  Regulation of protein kinase D1 activity.

Authors:  Susan F Steinberg
Journal:  Mol Pharmacol       Date:  2011-12-21       Impact factor: 4.436

Review 7.  Targeting reactive oxygen species in development and progression of pancreatic cancer.

Authors:  Nisha Durand; Peter Storz
Journal:  Expert Rev Anticancer Ther       Date:  2016-11-23       Impact factor: 4.512

8.  Loss of cell-cell contacts induces NF-kappaB via RhoA-mediated activation of protein kinase D1.

Authors:  Catherine F Cowell; Irene K Yan; Tim Eiseler; Amanda C Leightner; Heike Döppler; Peter Storz
Journal:  J Cell Biochem       Date:  2009-03-01       Impact factor: 4.429

9.  Rottlerin inhibits ROS formation and prevents NFkappaB activation in MCF-7 and HT-29 cells.

Authors:  Emanuela Maioli; Lucedio Greci; Karel Soucek; Martina Hyzdalova; Alessandra Pecorelli; Vittoria Fortino; Giuseppe Valacchi
Journal:  J Biomed Biotechnol       Date:  2010-02-03

10.  The protein kinase D1 COOH terminus: marker or regulator of enzyme activity?

Authors:  Weihua Qiu; Fan Zhang; Susan F Steinberg
Journal:  Am J Physiol Cell Physiol       Date:  2014-07-30       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.